FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY

Show other versions (1)

Aim. To compare effects of eprosartan and enalapril on free-radical oxidation in patients with acute myocardial infarction (AMI) without Q wave.Material and methods. 50 patients (aged 52,8±3,3 y.o.) with AMI without Q were involved into the study. Patients were randomized on 2 groups. The first grou...

Full description

Bibliographic Details
Main Authors:	O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ace inhibitors angiotensin receptor antagonists free-radical oxidation acute myocardial infarction
Online Access:	https://www.rpcardio.online/jour/article/view/661

Similar Items

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY
by: O. G. Zaylobidinov, et al.
Published: (2016-01-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
by: Azadeh Khalili, et al.
Published: (2021-07-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives
by: Attila Nagy, et al.
Published: (2023-12-01)

LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CORONARY HEART DISEASE: ASSESSMENT OF TELMISARTAN AND ENALAPRIL EFFECTIVENESS
by: I. P. Tatarchenko, et al.
Published: (2010-02-01)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
by: Nagaraja Moorthy, et al.
Published: (2021-02-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
by: Hye-Jin Park, et al.
Published: (2022-01-01)

The effect of aspirin therapy on the plasma renin activity in myocardial infarction
by: M.H Ansari, et al.
Published: (1995-07-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart
by: Vimal Agrawal, et al.
Published: (2016-11-01)

Influence of myocardial infarction on changes in the expression of angiotensin type 1 receptor in the rat prostate
by: Kamila Domińska, et al.
Published: (2011-10-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

AN ISSUE OF DRUG INTERACTION IN CARDIOLOGICAL PRACTICE: WHAT SHALL PHYSICIAN BE AWARE OF?
by: E. I. Tarlovskaya, et al.
Published: (2015-12-01)

Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients
by: Wiam Hmimech, et al.
Published: (2017-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
by: Masanobu Ishii, MD, et al.
Published: (2017-12-01)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
by: Rinaldo Bellomo, et al.
Published: (2020-02-01)

Acute Myocardial Infarction following Naltrexone Consumption; a Case Report
by: Bita Dadpour, et al.
Published: (2016-12-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry
by: Chan Soon Park, et al.
Published: (2022-08-01)

Skin Reactions with Losartan and Enalapril in Cardiac Patients
by: Fariba Iraji, et al.
Published: (2012-03-01)

Medicines in the rehabilitation of patients after myocardial infarction: angiotensin-converting enzyme inhibitors
by: A. S Galyavich
Published: (2010-03-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Renin Angiotensin System (RAS) Pathways in COVID Pathogenesis
by: Sampreeti Mukherjee, et al.
Published: (2023-01-01)

Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
by: Seema Bawa, et al.
Published: (2019-03-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation
by: Yong Hoon Kim, et al.
Published: (2020-01-01)

Knockout of ACE-N facilitates improved cardiac function after myocardial infarction
by: Hamid Suhail, et al.
Published: (2023-03-01)

ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure
by: Wolf-Stephan Rudi, et al.
Published: (2021-03-01)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
by: Akif Arslan, et al.
Published: (2016-01-01)

Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non‐Obstructive Coronary Arteries
by: Eun Ho Choo, et al.
Published: (2019-07-01)

Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
by: Renata Aiglova, et al.
Published: (2022-09-01)

Heart failure as a complication of myocardial infarction: rational therapy. Case report
by: Igor V. Zhirov, et al.
Published: (2022-12-01)

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease
by: Robert MacLachlan, et al.
Published: (2023-01-01)

ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
by: Jianqing She, et al.
Published: (2021-12-01)

Enalapril‐induced angioedema: A forgotten adverse event
by: María Carolina Manzur‐Barbur, et al.
Published: (2022-06-01)

Renin-angiotensin and kallikrein-kinin systems in diabetic retinopathy
by: Igić Rajko
Published: (2019-01-01)